​

Vitasora Health Limited

OTCPK:VHLU.F Stock Report

Market Cap: US$29.9m

Vitasora Health (VHLU.F) Stock Overview

An e-health SaaS company, researches, develops, and commercializes medical devices in Australia and the United States. More details

VHLU.F fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Risk Analysis

Shareholders have been substantially diluted in the past year

Shares are highly illiquid

Does not have a meaningful market cap ($46M)

Does not have meaningful revenue (A$2M)


VHLU.F Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

INBS logo
Intelligent Bio Solutions
JO
Jolt_Communications
Community Contributor

The Future of Drug Testing? Fingerprint Tech Shows Serious Promise

Key Takeaways Intelligent Bio Solutions has a new way to test for drugs using fingerprints: it’s quick, portable, and doesn’t require pee cups or saliva swabs. With commercial traction in 24 countries and over 450 active accounts, INBS is now targeting the U.S. market, where over 55 million drug tests are performed annually.
View narrative
US$2.98
FV
42.6% undervalued intrinsic discount
59.20%
Revenue growth p.a.
10users have liked this narrative
0users have commented on this narrative
57users have followed this narrative
about 1 month ago author updated this narrative

Vitasora Health Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Vitasora Health
Historical stock prices
Current Share PriceAU$0.058
52 Week HighAU$0.058
52 Week LowAU$0.055
Beta-0.45
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Change93.67%
5 Year Change0.17%
Change since IPO205.79%

Recent News & Updates

Recent updates

Shareholder Returns

VHLU.FUS Medical EquipmentUS Market
7D0%-1.5%0.4%
1Yn/a10.7%12.6%

Return vs Industry: Insufficient data to determine how VHLU.F performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how VHLU.F performed against the US Market.

Price Volatility

Is VHLU.F's price volatile compared to industry and market?
VHLU.F volatility
VHLU.F Average Weekly Movementn/a
Medical Equipment Industry Average Movement8.3%
Market Average Movement7.1%
10% most volatile stocks in US Market17.3%
10% least volatile stocks in US Market3.7%

Stable Share Price: VHLU.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine VHLU.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1987n/aMarjan Mikelvitasorahealth.com.au

Vitasora Health Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia and the United States. The company develops, produces, and sells mobile health applications. Its products include wheezo, a wheeze rate detector; respiri mobile application; and Respiri health portal.

Vitasora Health Limited Fundamentals Summary

How do Vitasora Health's earnings and revenue compare to its market cap?
VHLU.F fundamental statistics
Market capUS$29.91m
Earnings (TTM)-US$4.96m
Revenue (TTM)US$1.21m
24.7x
P/S Ratio
-6.0x
P/E Ratio

Is VHLU.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VHLU.F income statement (TTM)
RevenueAU$1.85m
Cost of RevenueAU$303.43k
Gross ProfitAU$1.55m
Other ExpensesAU$9.13m
Earnings-AU$7.58m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.0048
Gross Margin83.63%
Net Profit Margin-408.98%
Debt/Equity Ratio0%

How did VHLU.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/08 10:43
End of Day Share Price 2025/06/03 00:00
Earnings2024/12/31
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Vitasora Health Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Soo RomanoffEdison Investment Research